Suchergebnisse - Ellwanger, Kristina
- Treffer 1 - 8 von 8
-
1
-
2
-
3
-
4
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies von Ellwanger, Kristina, Reusch, Uwe, Fucek, Ivica, Knackmuss, Stefan, Weichel, Michael, Gantke, Thorsten, Molkenthin, Vera, Zhukovsky, Eugene A., Tesar, Michael, Treder, Martin
Veröffentlicht 2017Text -
5
Targeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density von Ellwanger, Kristina, Saito, Hiroaki, Clément-Lacroix, Philippe, Maltry, Nicole, Niedermeyer, Joachim, Lee, Woon Kyu, Baron, Roland, Rawadi, Georges, Westphal, Heiner, Niehrs, Christof
Veröffentlicht 2008Text -
6
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity von Ellwanger, Kristina, Reusch, Uwe, Fucek, Ivica, Wingert, Susanne, Ross, Thorsten, Müller, Thomas, Schniegler-Mattox, Ute, Haneke, Torsten, Rajkovic, Erich, Koch, Joachim, Treder, Martin, Tesar, Michael
Veröffentlicht 2019Text -
7
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors von Wingert, Susanne, Reusch, Uwe, Knackmuss, Stefan, Kluge, Michael, Damrat, Michael, Pahl, Jens, Schniegler-Mattox, Ute, Mueller, Thomas, Fucek, Ivica, Ellwanger, Kristina, Tesar, Michael, Haneke, Torsten, Koch, Joachim, Treder, Martin, Fischer, Wolfgang, Rajkovic, Erich
Veröffentlicht 2021Text -
8
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2 von Schulze, Jochen, Seitz, Sebastian, Saito, Hiroaki, Schneebauer, Michael, Marshall, Robert P., Baranowsky, Anke, Busse, Bjoern, Schilling, Arndt F., Friedrich, Felix W., Albers, Joachim, Spiro, Alexander S., Zustin, Jozef, Streichert, Thomas, Ellwanger, Kristina, Niehrs, Christof, Amling, Michael, Baron, Roland, Schinke, Thorsten
Veröffentlicht 2010Text